SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION ARTICLE M impact

Eledon submits tegoprubart islet transplantation IND; first patients enrolled

Eledon Pharmaceuticals submitted an IND to the FDA for an Eledon-sponsored registrational tegoprubart islet cell transplantation study for type 1 diabetes. It also enrolled first patients in a new investigator-initiated tegoprubart study in renal dysfunction patients.

ELDN

Eledon submitted an IND to the FDA for its sponsored registrational study of tegoprubart in islet cell transplantation for patients with type 1 diabetes. The company also said the first patients have been enrolled in a new investigator-initiated study of tegoprubart in patients with renal dysfunction receiving an islet cell transplant. The first patient…

Related stories